Clinical Trials Browser

Phase 1/2 × Lymphoma, Follicular × polatuzumab vedotin × Clear all

NCT04491370 2026-04-15

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT02600897 2023-12-26

A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 1/2 Completed

114 enrolled 34 charts

Lymphoid

Lymphoma, Follicular, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01691898 2020-02-21

ROMULUS

Phase 1/2 Completed

231 enrolled 64 charts

Lymphoid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse